Hopp til hovedinnhold

Prostataspesifikt antigen, PSA

Sist revidert:
Sist revidert av:

  1. Friis-Hansen L, Hornung N, et al. Prostataspecifikt antigen (PSA). Lægehåndbogen, sist oppdatert 07.09.2017.
  2. PSA, P. Nasjonal brukerhåndbok i Medisinsk Biokjemi, sist oppdatert 07.03.2019. www.prosedyrer.no  
  3. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database of Systematic Reviews 2013; 1: CD004720. doi: 10.1002/14651858.CD004720.pub3. DOI  
  4. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years follow-up. N Engl J Med 2012; 366: 981-90. New England Journal of Medicine  
  5. Eide IA, Angelsen A. Prostataspesifikt antigen. Tidsskr Nor Lægeforen 2000; 120: 2528-31. Tidsskrift for Den norske legeforening  
  6. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level <= 4.0 ng per milliliter. N Engl J Med 2004; 350: 2239-46. New England Journal of Medicine  
  7. Jiandani D, Randhawa A, Brown RE, et al. The effect of bicycling on PSA levels: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2015: 18: 208-12. PMID: 25939515 PubMed  
  8. Angelsen A, Hole A, Lundmo P, Romslo I. PSA and digital rectal examination. Clin Chem 1992; 38: 782. PubMed  
  9. Oesterling JE, Rice DC, Glenski WJ et al. Effects of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993;42: 276-82. PubMed  
  10. Eastham JA, Riedel E, Scardino PT, et al. Variation of serum prostate-specific antigen levels. An evaluation of year-to-year fluctuations. JAMA 2003; 289: 2695-2700. Journal of the American Medical Association  
  11. D'Amico AV, Chen M-H, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy . N Engl J Med 2004; 351: 125-35. PubMed  
  12. Ito K, Yamamoto T, Ohi M, et al. Free/totaL PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4,1 to 10,0 ng/mL. Urology 2003; 61: 760-4. PubMed  
  13. Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when. An update. Can J Urol 2005; 12: 44-8. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim, tilpasning til NEL

Tidligere fagmedarbeidere

  • Geir Thue, spesialist i alllmennmedisin, dr. med. NOKLUS og Oasen Legesenter, Bergen
  • Sverre Sandberg, overlege ved Nasjonalt kompetansesenter for porfyrisykdommer, Laboratorium for klinisk biokjemi, Haukeland Sykehus og professor i allmennmedisin, Seksjon for allmennmedisin, Universitetet i Bergen
  • Lennart Friis-Hansen, overlæge, dr. med., Klinisk Biokemisk afdeling, Næstved Sygehus (Lægehåndbogen)
  • Nete Hornung, Led. overlæge, klinisk lektor, ph.d., Klinisk biokemisk afdeling, Regionshospitalet Randers (Lægehåndbogen)